138 related articles for article (PubMed ID: 34504976)
1.
Apuzzo CF; Sullivan EC; Platt DC; Seger-Held I; Jones MA
Heliyon; 2021 Sep; 7(9):e07896. PubMed ID: 34504976
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the
Terry K; Drinkwater J; Jones MA; Sullivan E
Heliyon; 2024 May; 10(9):e30634. PubMed ID: 38742078
[TBL] [Abstract][Full Text] [Related]
3. Effects of Specific Electric Field Stimulation on the Release and Activity of Secreted Acid Phosphatases from
Dorsey BM; Cass CL; Cedeño DL; Vallejo R; Jones MA
Pathogens; 2018 Sep; 7(4):. PubMed ID: 30261701
[TBL] [Abstract][Full Text] [Related]
4. In vitro leishmanicidal activity of antimicrobial peptide KDEL against Leishmania tarentolae.
Cao L; Jiang W; Cao S; Zhao P; Liu J; Dong H; Guo Y; Liu Q; Gong P
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1286-1292. PubMed ID: 31761925
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Polycyclic Ether-Benzopyrans and In Vitro Inhibitory Activity against
Singh S; Grabowski JP; Pohani S; Apuzzo CF; Platt DC; Jones MA; Mitchell TA
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233418
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamides as Inhibitors of
Katinas J; Epplin R; Hamaker C; Jones MA
Antiinfect Agents; 2017 Apr; 15(1):57-62. PubMed ID: 29399442
[TBL] [Abstract][Full Text] [Related]
7. Evidence That Speciation of Oxovanadium Complexes Does Not Solely Account for Inhibition of
Dorsey BM; McLauchlan CC; Jones MA
Front Chem; 2018; 6():109. PubMed ID: 29707535
[TBL] [Abstract][Full Text] [Related]
8. Arginase/nitric oxide modifications using live non-pathogenic
Badirzadeh A; Montakhab-Yeganeh H; Miandoabi T
J Parasit Dis; 2021 Mar; 45(1):65-71. PubMed ID: 33746388
[TBL] [Abstract][Full Text] [Related]
9. Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against
Zaman SM; Jones MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770614
[TBL] [Abstract][Full Text] [Related]
10. A Novel Anti-Microbial Peptide from Pseudomonas, REDLK Induced Growth Inhibition of Leishmania tarentolae Promastigote In Vitro.
Yu Y; Zhao P; Cao L; Gong P; Yuan S; Yao X; Guo Y; Dong H; Jiang W
Korean J Parasitol; 2020 Apr; 58(2):173-179. PubMed ID: 32418386
[TBL] [Abstract][Full Text] [Related]
11. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
12. Isolation, characterization, and functional study of extracellular vesicles derived from
Shokouhy M; Sarvnaz H; Taslimi Y; Lajevardi MS; Habibzadeh S; Mizbani A; Shekari F; Behbahani M; Torrecilhas AC; Rafati S
Front Cell Infect Microbiol; 2022; 12():921410. PubMed ID: 35992172
[No Abstract] [Full Text] [Related]
13. Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
Zahedifard F; Gholami E; Taheri T; Taslimi Y; Doustdari F; Seyed N; Torkashvand F; Meneses C; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2751. PubMed ID: 24675711
[TBL] [Abstract][Full Text] [Related]
14. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice.
Montakhab-Yeganeh H; Abdossamadi Z; Zahedifard F; Taslimi Y; Badirzadeh A; Saljoughian N; Taheri T; Taghikhani M; Rafati S
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28833211
[TBL] [Abstract][Full Text] [Related]
15.
Lajevardi MS; Gholami E; Taheri T; Sarvnaz H; Habibzadeh S; Seyed N; Mortazavi Y; Rafati S
Front Immunol; 2022; 13():895234. PubMed ID: 35757692
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro.
Turner TL; Nguyen VH; McLauchlan CC; Dymon Z; Dorsey BM; Hooker JD; Jones MA
J Inorg Biochem; 2012 Mar; 108():96-104. PubMed ID: 22005446
[TBL] [Abstract][Full Text] [Related]
17. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis.
Ávila Brustolin A; Fernandes Herculano Ramos-Milaré ÁC; Perles de Mello TF; Alessi Aristides SM; Campana Lonardoni MV; Verzignassi Silveira TG
Exp Parasitol; 2022; 236-237():108244. PubMed ID: 35259404
[TBL] [Abstract][Full Text] [Related]
19. Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum.
Habibzadeh S; Doroud D; Taheri T; Seyed N; Rafati S
Iran Biomed J; 2021 Sep; 25(5):349-58. PubMed ID: 34481426
[TBL] [Abstract][Full Text] [Related]
20. Detection of Leishmania tarentolae in lizards, sand flies and dogs in southern Italy, where Leishmania infantum is endemic: hindrances and opportunities.
Mendoza-Roldan JA; Latrofa MS; Iatta R; R S Manoj R; Panarese R; Annoscia G; Pombi M; Zatelli A; Beugnet F; Otranto D
Parasit Vectors; 2021 Sep; 14(1):461. PubMed ID: 34493323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
